| Mrs Tracy Lynn Lewis, RN | |
|
907 West St, Laurel, DE 19956-1931 | |
| (302) 645-3300 | |
| Not Available |
| Full Name | Mrs Tracy Lynn Lewis |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 907 West St, Laurel, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962890830 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | L1-0027915 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tracy Lynn Lewis, RN 907 West St, Laurel, DE 19956-1931 Ph: (302) 645-3300 | Mrs Tracy Lynn Lewis, RN 907 West St, Laurel, DE 19956-1931 Ph: (302) 645-3300 |
News Archive
Traumatic brain injuries from sports, recreational activities, falls or car accidents are the leading cause of death and disability in children and adolescents. While previously it was believed that the window for brain recovery was at most one year after injury, new research from the Center for BrainHealth at The University of Texas at Dallas published online today in the open-access journal Frontiers in Neurology shows cognitive performance can be improved to significant degrees months, and even years, after injury, given targeted brain training.
University of Adelaide research is showing that the sex of the baby determines the way it responds to stressors during pregnancy and its ability to survive pregnancy complications.
ISPOR, the professional society for health economics and outcomes research, held a panel session this afternoon, "Should We Move Beyond Conventional Cost-Effectiveness Analysis? If So, How? [IP5]," at ISPOR 2018 in Baltimore, MD, USA.
Betalin Therapeutics, a biotech company specializing in tissue engineering for curing diabetes, introduces the Engineered Micro Pancreas (EMP), a novel technology that provides significant levels of glucose-regulated insulin secretion over extended periods of time.
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
› Verified 2 days ago
Jessica Burton, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 30915 Manchester Ln, Laurel, DE 19956 Phone: 302-542-0092 | |
Janette Mccoy, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1160 S Central Ave, Laurel, DE 19956 Phone: 302-684-4950 Fax: 302-684-8931 | |
Joan Adkins, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1160 S Central Ave, Laurel, DE 19956 Phone: 302-684-4950 Fax: 302-684-8931 | |
Vivian Short, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 815 S Central Ave, Laurel, DE 19956 Phone: 302-875-6105 | |
Mrs. Jennifer Michelle Chisley, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4526 Old Sharptown Rd, Laurel, DE 19956 Phone: 302-236-7614 | |
Melissa M Kestler, DNP, FNP-BC Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 30668 Sussex Hwy, Laurel, DE 19956 Phone: 302-875-6550 | |
Ms. Elizabeth Anna Kimbler, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 31869 Old Hickory Rd, Laurel, DE 19956 Phone: 302-249-4863 |